EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE

30 reported adverse events

Drug classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

These side effects are most commonly reported by patients taking EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE:

# Side effect Count
0 ANHEDONIA 8
1 ANXIETY 8
2 EMOTIONAL DISTRESS 8
3 PAIN 8
4 BONE DENSITY DECREASED 6
5 FOETAL EXPOSURE DURING PREGNANCY 4
6 HEADACHE 4
7 OSTEOPOROSIS 4
8 RENAL FAILURE 4
9 BACK PAIN 3
See all common reactions for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE

EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL SKIN DIMPLES 1 0.0041
1 BONE DEMINERALISATION 3 0.0028
2 CENTRAL NERVOUS SYSTEM VASCULITIS 1 0.0020
3 MALARIA 1 0.0014
4 CSF PROTEIN INCREASED 1 0.0012
5 ANOGENITAL WARTS 1 0.0011
6 MENINGITIS CRYPTOCOCCAL 1 0.0006
7 BLOOD HIV RNA INCREASED 1 0.0006
8 HAEMANGIOMA 1 0.0004
9 UMBILICAL HERNIA 2 0.0004
See all enriched reactions for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE